CARMEN ADDINGTON: Open Payments
NPI 1639625965 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 57 payments from 22 companies in 2025. Trend: 2023 $582 · 2024 $769 · 2025 $1,317
Food & beverage: $1,267Education: $50
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $264 |
| Amgen Inc. | 11 | $178 |
| Sequel Med Tech, LLC | 2 | $114 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $90 |
| BETA BIONICS, INC. | 2 | $76 |
| KYOWA KIRIN, INC. | 3 | $73 |
| Corcept Therapeutics | 4 | $68 |
| ABBVIE INC. | 3 | $64 |
| Insulet Corporation | 3 | $56 |
| Lilly USA, LLC | 2 | $45 |
Products named: Wegovy, TEPEZZA, TWIIST, ISTURISA, iLet Bionic Pancreas, CRYSVITA, Korlym, Omnipod.
Industry payments across TX — which companies pay providers there.
